Transgene
Clinical trials sponsored by Transgene, explained in plain language.
-
New combo therapy tested in fight against tough HPV cancers
Disease control OngoingThis study is testing a combination of two drugs, TG4001 and avelumab, for people with advanced HPV-16 cancers that have returned or spread. The goal is to see if the combination is safe and if it helps shrink tumors or slow their growth. It includes adults with certain cancers l…
Phase: PHASE1, PHASE2 • Sponsor: Transgene • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Personalized vaccine trial aims to train immune system to fight cancer recurrence
Disease control OngoingThis trial is testing a personalized immunotherapy called TG4050 in patients with advanced head and neck cancer who have completed initial treatment. The goal is to see if this vaccine, designed to target each patient's specific cancer mutations, is safe and can help prevent the …
Phase: PHASE1, PHASE2 • Sponsor: Transgene • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC